Clinical: Infrared Thermography Fails to Predict Breast Malignancy
By: MIRIAM E. TUCKER, Oncology Report Digital Network, from the Annual Meeting of the American Society of Breast Surgeons
Several quotes from this article:
Infrared thermography did not accurately predict malignancy and produced an unacceptably high false-positive rate in women with radiologic abnormalities requiring breast biopsy in a 2-year prospective study.
The technology is being explored as an alternative to radiation-based imaging in women at risk for breast cancer and as a way to reduce the number of benign biopsies, Dr. Andrea V. Barrio said during a press briefing at the annual meeting of the American Society of Breast Surgeons.
This study evaluated NTBS screening as a predictor of breast cancer in patients undergoing minimally invasive breast biopsy for suspicious mammogram, ultrasound, or MRI findings.
But the results demonstrated that NTBS “cannot be used as a successful adjunct to mammography, nor can it replace any of the screening modalities that are standard practice. Mammography remains the gold standard for breast cancer screening,” said Dr. Barrio, an attending breast surgeon at Bryn Mawr (Pa.) Hospital.
Read the rest of this article on The Oncolocy Report at: http://www.oncologyreport.com/news/clinical/single-article/infrared-thermography-fails-to-predict-breast-malignancy/b715307977d5545c57292d877046d879.html